What is Cronos Group's market cap?

Cronos Group (CRON) has a market capitalization of $1.1B and trades on NASDAQ.

What is Cronos Group's revenue and profitability?

Cronos Group generated $159.5M in trailing twelve-month revenue with a net loss of $1.8M, representing a net margin of -1.1%. Gross margin stands at 42.7%, with free cash flow of $26.5M. These figures are based on the Q1 2026 filing.

Who are Cronos Group's competitors?

Cronos Group's key competitors include Canopy Growth Corporation, Tilray Brands, Inc., Aurora Cannabis Inc., and others. These companies compete in similar markets and product categories.

Who does Cronos Group partner with?

Cronos Group's notable partners include Altria Group, Inc., Cansativa, Ginkgo Bioworks Holdings, Inc., and others.

What subsidiaries does Cronos Group have?

Cronos Group's subsidiaries include Peace Naturals Project Inc., Cronos GrowCo, Cronos Israel.

Where is Cronos Group headquartered?

Cronos Group is headquartered in Canada and employs approximately 356 people. It has been publicly traded since 2016.

Cronos Group

CRON

Cronos Group is an innovative global cannabinoid company focused on advancing cannabis research, technology, and product development.

Market cap

$1.07B+38.6%

Revenue$159.5M+28.1%

Net income-$1.8M-104%

Free cash flow$26.5M+479%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 11, 2026

Revenue$45.2MBeat by $3.0M EPS$0.01In line

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$44.2M

EPS estimate$0.01

Financials

Q1 2026

Income statement

See full

Revenue$45.2M+40.1%

Gross profit$19.2M+39.5%

Operating income-$1.8M+55.0%

Net income$13.8M+125%

EPS (diluted)$0.04+100%

Balance sheet

See full

Cash & equivalents$821.9M+3.0%

Total debt$1.3M-27.8%

Total equity$1.1B+0.7%

Total assets$1.2B+1.6%

Cash flow

See full

Operating cash flow$10.9M+620%

CapEx$1.9M-87.7%

Free cash flow$9.0M+152%

Valuation & ratios

Valuation

See full

Market cap$1.07B+38.6%

Enterprise value$248.13M+15,824%

P/S6.7×+0.6×

Profitability

See full

Gross margin42.7%+15.1pp

Operating margin-9.5%-4.3pp

Net margin-1.1%-40.8pp

FCF margin16.6%+13.3pp

Returns & leverage

See full

Return on equity-0.2%-4.8pp

Debt / equity0×0.0×

Current ratio21.9×-5.9×

Segments

By product

See full

Cannabis flower$33.7M+44.5%

Cannabis extracts$11.5M+33.1%

Competitors

By market cap

Innovative Industrial Properties, Inc.$1.8B+19.6%

Cronos Group$1.1B+34.6%

Tilray Brands, Inc.$497.5M-30.9%

Canopy Growth Corporation$390.2M+91.5%

Village Farms International, Inc.$247.3M+49.7%

Aurora Cannabis Inc.$169.7M-36.9%

eXoZymes, Inc.$42.2M-49.2%

InMed Pharmaceuticals$8.8M+65.7%

By revenue growth

Cronos Group+28.1%

Village Farms International, Inc.+17.0%

Tilray Brands, Inc.+11.5%

Canopy Growth Corporation+5.8%

Innovative Industrial Properties, Inc.-13.6%

By net margin

Innovative Industrial Properties, Inc.45.58%-4.7pp

Village Farms International, Inc.18.57%+39.1pp

Cronos Group-1.14%-40.8pp

Tilray Brands, Inc.-11.99%+254pp

Canopy Growth Corporation-92.38%+96.8pp

eXoZymes, Inc.-2,909.12%—

Profile

Cronos Group is an innovative global cannabinoid company focused on advancing cannabis research, technology, and product development. The company builds and manages a diverse portfolio of international brands across adult-use and medical markets. Its core value proposition centers on creating disruptive intellectual property and maintaining a global distribution network to responsibly elevate the consumer experience.

Competitive position

Cronos is a well-capitalized global player supported by a strategic investment from Altria, focusing on premium brand differentiation and IP-driven product innovation.

GeographiesCanada, Israel, Germany, United Kingdom, Australia, Switzerland

Customer segmentsGovernment Agencies, Medical Patients, Retail Consumers

Business modelManufacturing, Wholesale, Licensing and IP, Direct-to-Patient

SuppliersAgricultural inputs, Greenhouse infrastructure, Laboratory testing services, Third-party cannabis flower suppliers

CustomersOntario Cannabis Retail Corporation, Alberta Gaming, Liquor and Cannabis Commission, Medical pharmacies, Private cannabis retailers

CountryCanada

Listed2016

Employees356.0

CEOMichael Ryan Gorenstein

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Websitethecronosgroup.com

FilingsSEC EDGAR

Ask your AI about Cronos Group.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cronos Group's market cap?: Cronos Group (CRON) has a market capitalization of $1.1B and trades on NASDAQ.
What is Cronos Group's revenue and profitability?: Cronos Group generated $159.5M in trailing twelve-month revenue with a net loss of $1.8M, representing a net margin of -1.1%. Gross margin stands at 42.7%, with free cash flow of $26.5M. These figures are based on the Q1 2026 filing.
Who are Cronos Group's competitors?: Cronos Group's key competitors include Canopy Growth Corporation, Tilray Brands, Inc., Aurora Cannabis Inc., and others. These companies compete in similar markets and product categories.
Who does Cronos Group partner with?: Cronos Group's notable partners include Altria Group, Inc., Cansativa, Ginkgo Bioworks Holdings, Inc., and others.
What subsidiaries does Cronos Group have?: Cronos Group's subsidiaries include Peace Naturals Project Inc., Cronos GrowCo, Cronos Israel.
Where is Cronos Group headquartered?: Cronos Group is headquartered in Canada and employs approximately 356 people. It has been publicly traded since 2016.